Last update 23 Jan 2025

Sciclone Pharmaceuticals Italy Srl

Subsidiary Company|
Italy

Overview

Tags

Digestive System Disorders
Neoplasms
Infectious Diseases
Synthetic peptide

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Infectious Diseases1
Neoplasms1
Top 5 Drug TypeCount
Synthetic peptide1
Top 5 TargetCount
5-HT6 receptor(Serotonin 6 (5-HT6) receptor)1

Related

1
Drugs associated with Sciclone Pharmaceuticals Italy Srl
Thymalfasin
Target
5-HT6 receptor
Mechanism
5-HT6 receptor antagonists
Active Org.
SciClone Pharmaceuticals LLCSciClone Pharmaceuticals LLC [+3]
Originator Org.
Sciclone Pharmaceuticals Italy Srl
Active Indication
Hepatitis B, Chronic [+3]
Inactive Indication
Hepatitis C, Chronic [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
CN
First Approval Date01 Jan 1996
1
Clinical Trials associated with Sciclone Pharmaceuticals Italy Srl
EUCTR2015-005605-36-IT
/ Not yet recruitingPhase 2
Thymosin alpha 1 plus maintenance therapy with the Standard of Care (SoC) chemotherapy plus cisplatin (or carboplatin) in patients with metastatic Non-Small Cell Lung Cancer (NSCLC), EGFR wild type - SCI-Ta1-NSCLC-CHEMO P2-001
100 Clinical Results associated with Sciclone Pharmaceuticals Italy Srl
Login to view more data
0 Patents (Medical) associated with Sciclone Pharmaceuticals Italy Srl
Login to view more data
100 Deals associated with Sciclone Pharmaceuticals Italy Srl
Login to view more data
100 Translational Medicine associated with Sciclone Pharmaceuticals Italy Srl
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 13 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Thymalfasin
 ( 5-HT6 receptor )		Hepatitis B, Chronic
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free